Balancing the Benefits of the New Anti-Obesity Medications with their Exorbitant Costs: What is a Self-Funded Employer to do? 

Abacus' Sr Scientist, David Ahern, PhD and his Co-Authors: Collin Smith, PharmD, Augustus E. Adams, PhD, Michael J. Follick, PhD recently penned an opinion piece on the Obesity epidemic and its effects on self-funded employers. The article published on Healthcare Business Today, explored the impacts of obesity on self-funded employer...

Do GLP medications save employers money? The answer is YES – when used as part of a comprehensive diabetes management plan that includes other key diabetes management behaviors.

In National Diabetes Awareness Month, Abacus Health Solutions announces the results of a cost savings analysis of their patented Diabetes Care Rewards Program. Over the last 17 years, Abacus has continued to innovate and provide its Diabetes Program to individuals through their employers. The Program incentivizes long-term health behaviors and...

Abacus partners with Health Action Council for education event.

Abacus Health's senior scientist, Dr. David K. Ahern is set to conduct an educational workshop for the Health Action Council's membership on May 21, 2019 entitled Bending the Diabetes Cost Trend. Dr. Ahern will share the results of a study summarizing a decade-long implementation of the Abacus Health Diabetes Care...